These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 220413

  • 1. The influence of corticosteroids on the secretion of corticotrophin and its hypothalamic releasing hormone.
    Buckingham JC.
    J Physiol; 1979 Jan; 286():331-42. PubMed ID: 220413
    [Abstract] [Full Text] [Related]

  • 2. Effects of treatment with adrenocorticotrophin on the hypothalamo-pituitary-adrenal system.
    Stark E, Kárteszi M, Rappay G, Makara GB.
    J Endocrinol; 1981 Jan; 88(1):131-9. PubMed ID: 6257818
    [Abstract] [Full Text] [Related]

  • 3. Effects of adrenalectomy and corticosterone replacement on the hypothalamic-pituitary response to neural stimuli.
    Weidenfeld J, Feldman S.
    Brain Res; 2000 Sep 15; 877(1):73-8. PubMed ID: 10980245
    [Abstract] [Full Text] [Related]

  • 4. Interleukin 1 stimulation of the hypothalamic-pituitary-adrenal axis.
    Gwosdow AR, Kumar MS, Bode HH.
    Am J Physiol; 1990 Jan 15; 258(1 Pt 1):E65-70. PubMed ID: 2154118
    [Abstract] [Full Text] [Related]

  • 5. Effects of naloxone on hypothalamo-pituitary-adrenocortical activity in the rat.
    Buckingham JC, Cooper TA.
    Neuroendocrinology; 1986 Jan 15; 42(5):421-6. PubMed ID: 3010154
    [Abstract] [Full Text] [Related]

  • 6. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by the type 4 phosphodiesterase (PDE-4) inhibitor, denbufylline.
    Hadley AJ, Kumari M, Cover PO, Osborne J, Poyser R, Flack JD, Buckingham JC.
    Br J Pharmacol; 1996 Oct 15; 119(3):463-70. PubMed ID: 8894165
    [Abstract] [Full Text] [Related]

  • 7. Abnormalities in the hypothalamo-pituitary-adrenal axis in spontaneously hypertensive rats during development of hypertension.
    Hashimoto K, Makino S, Hirasawa R, Takao T, Sugawara M, Murakami K, Ono K, Ota Z.
    Endocrinology; 1989 Sep 15; 125(3):1161-7. PubMed ID: 2547578
    [Abstract] [Full Text] [Related]

  • 8. Dopamine-beta-hydroxylase activity is necessary for hypothalamo-pituitary-adrenal (HPA) responses to ether, and stress-induced facilitation of subsequent HPA responses to acute ether emerges as HPA responses are inhibited by increasing corticosterone (B).
    Murakami K, Akana SF, Dallman MF.
    J Neuroendocrinol; 1997 Aug 15; 9(8):601-8. PubMed ID: 9283048
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
    Calogero AE, Kamilaris TC, Gomez MT, Johnson EO, Tartaglia ME, Gold PW, Chrousos GP.
    Endocrinology; 1989 Nov 15; 125(5):2445-53. PubMed ID: 2551652
    [Abstract] [Full Text] [Related]

  • 11. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
    Thomas GB, Fairhall KM, Robinson IC.
    Endocrinology; 1997 Apr 15; 138(4):1585-91. PubMed ID: 9075719
    [Abstract] [Full Text] [Related]

  • 12. CRH mRNA expression in the hypothalamic paraventricular nucleus is inhibited despite the activation of the hypothalamo-pituitary-adrenal axis during starvation.
    Nishiyama M, Makino S, Iwasaki Y, Tanaka Y, Nazarloo HP, Kaneda T, Asaba K, Hashimoto K.
    Brain Res; 2008 Sep 04; 1228():107-12. PubMed ID: 18619422
    [Abstract] [Full Text] [Related]

  • 13. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD, Oitzl MS, Workel JO, de Kloet ER.
    Endocrinology; 1996 Nov 04; 137(11):4935-43. PubMed ID: 8895366
    [Abstract] [Full Text] [Related]

  • 14. Attenuated neuroendocrine responses to emotional and physical stressors in pregnant rats involve adenohypophysial changes.
    Neumann ID, Johnstone HA, Hatzinger M, Liebsch G, Shipston M, Russell JA, Landgraf R, Douglas AJ.
    J Physiol; 1998 Apr 01; 508 ( Pt 1)(Pt 1):289-300. PubMed ID: 9490853
    [Abstract] [Full Text] [Related]

  • 15. Corticotrope response to removal of releasing factors and corticosteroids in vivo.
    Dallman MF, Makara GB, Roberts JL, Levin N, Blum M.
    Endocrinology; 1985 Nov 01; 117(5):2190-7. PubMed ID: 2995008
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Chronic melatonin treatment and the hypothalamo-pituitary-adrenal axis in the rat: attenuation of the secretory response to stress and effects on hypothalamic neuropeptide content and release.
    Konakchieva R, Mitev Y, Almeida OF, Patchev VK.
    Biol Cell; 1997 Dec 01; 89(9):587-96. PubMed ID: 9673011
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Role of the hypothalamic-pituitary-adrenal axis in the suppression of luteinizing hormone release by delta-9-tetrahydrocannabinol.
    Jackson AL, Murphy LL.
    Neuroendocrinology; 1997 Jun 01; 65(6):446-52. PubMed ID: 9208407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.